SCHEMBL8680964

SCHEMBL8680964

CCCCCCCCCCCCCCCCCC(CC)OC(=O)OC1CCCC[N]1

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 3/20 0.37
EPHX2 P34913 2/20 0.33
PRKCA P17252 1/20 0.32
PRKCD Q05655 1/20 0.32
PLA2G2C Q5R387 1/20 0.32
ALDH1A1 P00352 1/20 0.31
KMT2A Q03164 1/20 0.31
CCR2 P41597 1/20 0.31
TSHR P16473 1/20 0.30
GLS2 Q9UI32 2/20 0.30
CNR1 P21554 2/20 0.30
DAGLA Q9Y4D2 2/20 0.30
CNR2 P34972 1/20 0.30
ZDHHC7 Q9NXF8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8683210 1.00 NAAA (0.37) NAAAEPHX2PRKCAPRKCDPLA2G2C
SCHEMBL8680799 1.00 NAAA (0.37) NAAAEPHX2PRKCAPRKCDPLA2G2C
SCHEMBL8681216 1.00 NAAA (0.37) NAAAEPHX2PRKCAPRKCDPLA2G2C
SCHEMBL8681297 1.00 NAAA (0.37) NAAAEPHX2PRKCAPRKCDPLA2G2C
SCHEMBL8681243 0.96 NAAA (0.35) NAAAEPHX2PRKCAPRKCDPLA2G2C
SCHEMBL8681205 0.96 NAAA (0.35) NAAAEPHX2PRKCAPRKCDPLA2G2C
SCHEMBL8683157 0.96 NAAA (0.35) NAAAEPHX2PRKCAPRKCDPLA2G2C
SCHEMBL8680824 0.96 NAAA (0.35) NAAAEPHX2PRKCAPRKCDPLA2G2C
SCHEMBL8683170 0.96 NAAA (0.35) NAAAEPHX2PRKCAPRKCDPLA2G2C
SCHEMBL8681042 0.96 NAAA (0.35) NAAAEPHX2PRKCAPRKCDPLA2G2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
EP-0790235-A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses SANKYO COMPANY LIMITED (JP) 1997-08-20 EP disclosed